Form 8-K - Current report:
SEC Accession No. 0001558370-25-008294
Filing Date
2025-05-30
Accepted
2025-05-30 16:05:26
Documents
17
Period of Report
2025-05-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250529x8k.htm   iXBRL 8-K 48633
2 EX-3.1 chrs-20250529xex3d1.htm EX-3.1 8489
3 EX-3.2 chrs-20250529xex3d2.htm EX-3.2 172382
4 EX-99.1 chrs-20250529xex99d1.htm EX-99.1 18010
5 GRAPHIC chrs-20250529xex99d1001.jpg GRAPHIC 9226
  Complete submission text file 0001558370-25-008294.txt   459535

Data Files

Seq Description Document Type Size
6 EX-101.SCH chrs-20250529.xsd EX-101.SCH 4128
7 EX-101.DEF chrs-20250529_def.xml EX-101.DEF 15164
8 EX-101.LAB chrs-20250529_lab.xml EX-101.LAB 20562
9 EX-101.PRE chrs-20250529_pre.xml EX-101.PRE 15640
19 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250529x8k_htm.xml XML 7196
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 251010801
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)